Correction to: British Journal of Cancer (2009) 100, 1666–1673, doi: 10.1038/sj.bjc.6605026
Upon publication of this paper in Volume 100, the authors noticed an error in the results section of the Abstract, where HIF-2α was expressed incorrectly as HIF-1α. The correction is now shown below in bold.
RESULTS: MVD was higher across T- and N-stages (P<0.001) and associated with poor survival (Hazard ratio (HR 8.7, P<0.005) and decreased disease-free survival (HR=4.7, P<0.005). HIF-1α and HIF-2α were expressed in >50% of rectal cancers (HIF-1α, 54%, 48/90; HIF-2α, 64%, 58/90). HIF-1α positivity was associated with TNM stage (P<0.05), vascular invasion (P<0.005), recurrence (HR=4.5, P<0.005) and cancer-specific mortality (HR=5.5, P<0.002). In contrast, no associations were demonstrated between HIF-2 α and any pathological features or outcome.
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Rasheed, S., Harris, A., Tekkis, P. et al. Correction: Hypoxia-inducible factor-1α and -2α are expressed in most rectal cancers but only hypoxia-inducible factor-1α is associated with prognosis. Br J Cancer 101, 742 (2009). https://doi.org/10.1038/sj.bjc.6605242
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6605242
